Measurement of endothelial function and its clinical utility for cardiovascular risk

Vascular Health and Risk Management

Volumn 4, Issue 3, 2008, Pages 647-652

  Al Qaisi, Mo ^a,c   Kharbanda, Rajesh K ^a   Mittal, Tarun K ^a   Donald, Ann E ^b  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c NONE   (United Kingdom)

Author keywords

Cardiovascular risk; Clinical utility; Endothelial function; Flow mediated dilatation

Indexed keywords

ARTERY BLOOD FLOW; ATHEROSCLEROSIS; AUTOMATION; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; ENVIRONMENTAL FACTOR; FALSE POSITIVE RESULT; FUNCTIONAL ASSESSMENT; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; INVASIVE PROCEDURE; LASER DOPPLER FLOWMETRY; METHODOLOGY; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PLETHYSMOGRAPHY; PRIMARY PREVENTION; PULSE WAVE; REPRODUCIBILITY; REVIEW; RISK ASSESSMENT; RISK FACTOR; STANDARDIZATION; STEREOTAXIS; TONOMETRY; VASCULAR ENDOTHELIUM; VASODILATATION;

ATHEROSCLEROSIS; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; HUMANS; LASER-DOPPLER FLOWMETRY; REGIONAL BLOOD FLOW; RISK ASSESSMENT; VASODILATION;

EID: 47849083953     PISSN: 11766344     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Agewall S, Doughty RN, Bagg W, et al. 2001. Comparison of ultrasound assessment of flow-mediated dilatation in the radial and brachial artery with upper and forearm cuff positions. Clin Physiol, 21:9-14.
2. Anderson EA and Mark AL. 1989. Flow-mediated and reflex changes in large peripheral artery tone in humans. Circulation, 79:93-100.
3. Anderson TJ. 2007. Prognostic significance of brachial flow-mediated vasodilation. Circulation, 115:2373-75.
4. Berry KL, Skyrme-Jones RA, Meredith IT. 2000. Occlusion cuff position is an important determinant of the time course and magnitude of human brachial artery flow-mediated dilation. Clin Sci (Lond), 99:261-7.
5. Bonetti PO, Pumper GM, Higano ST et al. 2004. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol, 44:2137-41.
6. Bots M, Westerink J, Rabelink TJ, et al. 2005. Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response. Eur Heart J, 26:363-8.
7. Celermajer DS, Sorensen KE, Gooch VM, et al. 1992. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet, 340:1111-15.
8. Celermajer DS, Sorensen KE, Bull C, et al. 1994. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol, 24:1468-74.
9. Celermajer DS, Ayer JG. 2006. Childhood risk factors for adult cardiovascular disease and primary prevention in childhood. Heart, 92:1701-6.
10. Chong WC, Collins P, Webb CM, et al. 2006. Comparison of flow characteristics and vascular reactivity of radial artery and long saphenous vein grafts. J Cardiothorac Surg, 1:4.
11. Charakida M, Donald AE, Terese M, et al. 2005. Endothelial dysfunction in childhood infection. Circulation, 111:1660-5.
12. Clarkson P, Adams MR, Powe AJ et al. 1996. Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. J Clin Invest, 97:1989-94.
13. Cooke JP, Dzau VJ. 1997. Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med, 48:489-509.
14. Corretti MC, Anderson TJ, Benjamin EJ, et al. 2002. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol, 39:257-65.
15. Corson MA, James NL, Latta SE, et al. 1996. Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress. Circ Res, 79:984-91.
16. Deanfield J, Donald A, Ferri C, et al. 2005. Endothelial function and dysfunction. Part 1: Methodological issues for assessment in the different vascular beds: A statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens, 23:7-17.
17. Deanfield JE, Halcox JP, Rabelink TJ. 2007. Endothelial function and dysfunction: testing and clinical relevance. Circulation, 115:1285-95.
18. Donald AE, Charakida M, Cole TJ, et al. 2006. Non-invasive assessment of endothelial function: which technique? J Am Coll Cardiol, 48:1846-50.
19. Doshi SN, Naka KK, Payne N, et al. 2001. Flow-mediated dilatation following wrist and upper arm occlusion in humans: the contribution of nitric oxide. Clin Sci (Lond), 101:629-35.
20. Duffy SJ, Keaney JF, Holbrook M, et al. 2001. Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation, 104:151-6.
21. Ford I, Murray H, Packard CJ, et al. 2007. Long-term follow-up of the West of Scotland Coronary Prevention Study. N Engl J Med, 357:1477-86.
22. Förstermann U, Münzel T. 2006. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation, 113:1708-14.
23. Furchgott RF, Zawadzki JV. 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288:373-76.
24. Gokce N, Keaney JF, Hunter LM, et al. 2003. Predictive value of non-invasively determined endothelial dysfunction for long-term cardio-vascular events in patients with peripheral vascular disease. J Am Coll Cardiol, 41:1769-75.
25. Guthikonda S, Sinkey CA, Haynes WG. 2007. What is the most appropriate methodology for detection of conduit artery endothelial dysfunction? Arterioscler Thromb Vasc Biol, 27:1172-6.
26. Halcox JP, Schenke WH, Zalos G, et al. 2002. Prognostic value of coronary vascular endothelial dysfunction. Circulation, 106:653-8.
27. Hansell J, Henareh L, Agewall S, et al. 2004. Non-invasive assessment of endothelial function - relation between vasodilatory responses in skin microcirculation and brachial artery. Clin Physiol Funct Imaging, 24:317-22.
28. Hashimoto M, Akishita M, Eto M, et al. 1995. Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation, 92:3431-5.
29. Herrington DM, Fan L, Drum M, et al. 2001. Brachial flow-mediated vasodilator responses in population-based research: methods, reproducibility and effects of age, gender and baseline diameter. J Cardiovasc Risk, 8:319-28.
30. Hingorani AD, Cross J, Kharbanda RK, et al. 2000. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation, 102:994-9.
31. Juonala M, Viikari JSA, Laitinen T, et al. 2004. Interrelations between brachial endothelial function and carotid intima-media thickness in young adults. The cardiovascular risk in young Finns study. Circulation, 110:2918-23.
32. Kharbanda RK, Deanfield JE. 2001. Functions of the healthy endothelium. Coron Artery Dis, 12:485-91.
33. Karatzis EN, Ikonomidis I, Vamvakou GD, et al. 2006. Long-term prognostic role of flow-mediated dilatation of the brachial artery after acute coronary syndromes without ST elevation. Am J Card, 98:1424-8.
34. Leeson CPM, Whincup PH, Cook DG, et al. 1997. Flow-mediated dilation in 9- to 11-year-old children: the influence of intrauterine and childhood factors. Circulation, 96:2233-8.
35. Leeson CP, Robinson M, Francis JM, et al. 2006. Cardiovascular magnetic resonance imaging for non-invasive assessment of vascular function: validation against ultrasound. J Cardiovasc Magn Reson, 8:381-7.
36. Matsushima Y, Takase B, Uehata A, et al. 2007. Comparative predictive and diagnostic value of flow-mediated vasodilation in the brachial artery and intima media thickness of the carotid artery for assessment of coronary artery disease severity. Int J Cardiol, 117:165-72.
37. Mullen MJ, Kharbanda RK, Cross J, et al, 2001. Heterogene ous nature of flow-mediated dilatation in human conduit arteries in vivo: relevance to endothelial dysfunction in hypercholesterolaemia. Circ Res, 88:145-51.
38. Nicholls SJ, Sipahi I, Schoenhagen P, et al. 2006. Intravascular ultrasound assessment of novel antiatherosclerotic therapies: rationale and design of the Acyl-CoA: Cholesterol Acyltransferase Intravascular Atherosclerosis Treatment Evaluation (ACTIVATE) Study. Am Heart J, 152:67-74.
39. Palinkas A, Toth E, Venneri L, et al. 2002. Temporal heterogeneity of endothelium-dependent and-independent dilatation of brachial artery in patients with coronary artery disease. Int J Cardiovasc Imaging, 18:337-42.
40. Peretz A, Leotta DF, Sullivan JH, et al. 2007. Flow mediated dilation of the brachial artery: an investigation of methods requiring further standardisation. BMC Cardiovasc Disord, 7:11.
41. Pohl U, Holtz J, Busse R, et al. 1986. Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension, 8:37-44.
42. Reilly JJ, Armstrong J, Dorosty AR, et al. 2005. Early life risk factors for obesity in childhood: cohort study. BMJ, 330:1357.
43. Rubanyi GM, Romero JC, Vanhoutte PM. 1996. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol, 250(6 Pt 2):H1145-9.
44. Sankatsing RR, de Groot E, Jukema JW, et al. 2005. Surrogate markers for atherosclerotic disease. Curr Opin Lipidol, 16:434-41.
45. Schechter AN, Gladwin MT. 2003. Haemoglobin and the paracrine and endocrine functions of nitric oxide. N Engl J Med, 384:1483-5.
46. Shimbo D, Grahame-Clarke C, Miyake Y, et al. 2007. The association between endothelial dysfunction and cardiovascular outcomes in a population-based multi-ethnic cohort. Atherosclerosis, 192:197-203.
47. Smiesko V, Kozik J, Dolezel S. 1985. Role of endothelium in the control of arterial diameter by blood flow. Blood Vessels, 22:247-51.
48. Strain WD, Chaturvedi N, Leggetter S, et al. 2005. Ethnic differences in skin microvascular function and their relation to cardiac target-organ damage. J Hypertens, 23:133-40.
49. Suessenbacher A, Frick M, Alber HF, et al. 2006. Association of improvement of brachial artery flow-mediated vasodilation with cardiovascular events. Vasc Med, 11:239-44.
50. Williams MJ, Sutherland WH, McConnick MP, et al. 1999. Impaired endothelial function following a meal rich in used cooking fat. J Am Coll Cardiol, 33:1050-5.
51. Witte DR, Westerlink J, de Koning EJ, et al. 2005. Is the association between flow-mediated dilation and cardiovascular risk limited to low-risk populations? J Am Coll Cardiol, 45:1987-93.
52. Yeboah J, Crousse JR, Hsu F, et al. 2007. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: The Cardiovascular Health Study. Circulation, 115:2390-97.